| P2093 | author name string | Lin Wang | |
| | Jie Cui | |
| | Na Zhao | |
| | Ke-Jun Nan | |
| | Ya-Huan Guo | |
| | Tao Tian | |
| P2860 | cites work | Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 |
| | Angiogenesis in cancer and other diseases | Q27861015 |
| | Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 |
| | Hepatocellular carcinoma | Q29615841 |
| | Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 |
| | Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors | Q33864448 |
| | Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin | Q33889173 |
| | Review: drug therapy in Chinese traditional medicine | Q33915969 |
| | Multicellular resistance: a paradigm for clinical resistance? | Q34060947 |
| | Systemic therapy for hepatocellular carcinoma | Q34422663 |
| | Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells. | Q34524031 |
| | The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma | Q35648702 |
| | Recent advances on ginseng research in China | Q35688406 |
| | Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 |
| | Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma | Q36673674 |
| | Hepatocellular carcinoma (HCC): an update | Q36797931 |
| | Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer | Q40144161 |
| | Liquid-overlay culture of cellular spheroids. | Q40201086 |
| | Predicting aggregation kinetics of DU 145 prostate cancer cells in liquid-overlay culture | Q40358274 |
| | The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro? | Q40630929 |
| | Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo | Q40729476 |
| | Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding | Q40935045 |
| | Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients | Q43850818 |
| | Induction of differentiation in human hepatocarcinoma cells by isoverbascoside | Q43978854 |
| | Tumor regression by targeted gene delivery to the neovasculature | Q44044889 |
| | Modulating angiogenesis: the yin and the yang in ginseng | Q45037076 |
| | Morphological and biochemical analysis of Rac1 in three-dimensional epithelial cell cultures. | Q46150566 |
| | Angiogenesis | Q56689455 |
| | Multicellular spheroids as an in vitro tumor model | Q77636375 |
| | Hepatocellular carcinoma | Q93930900 |
| P433 | issue | 41 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 5432-5439 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture | |
| P478 | volume | 13 | |